LINC01606

Across TCGA pan-cancer cohorts, LINC01606 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01606 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01606 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01606 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

UVM, STAD, and KIRP are the cancer types where LINC01606 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.431	0.731	<.001	127	view →
STAD	DFS	Tertile	II,III,IV	0.328	0.545	.001	63	view →
KIRP	OS	Tertile	II,III,IV	0.307	0.724	<.001	54	view →
ACC	OS	Tertile	All	0.195	0.775	<.001	54	view →
BLCA	OS	Tertile	All	0.441	0.658	<.001	52	view →
UCEC	DFS	Quartile	All	0.833	0.911	.003	36	view →
COAD	DFS	Tertile	All	0.586	0.725	.003	30	view →
PAAD	DFS	Median	II,III,IV	0.532	0.358	.014	18	view →
SKCM	OS	Tertile	All	0.892	0.830	.012	11	view →
ESCA	OS	Quartile	II,III,IV	0.371	0.629	.007	11	view →
CHOL	DFS	Quartile	III,IV	0.091	0.806	.038	9	view →
MESO	DFS	Tertile	IV	0.127	0.405	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01606–UVM (DFS)

Open the UVM breakdown →